Provectus Biopharmaceuticals Names Dominic Rodrigues Principal Executive Officer; Bruce Horowitz Resigns

PROVECTUS BIOPHARMACEUTICALS, INC.

Bruce Horowitz resigned as COO and Director on March 25, 2024, and entered a termination agreement with a total payment of up to $750,000.
The termination agreement includes an initial $250,000 payment and a second payment of $258,000 if paid before June 30, 2024, otherwise $500,000.
Dominic Rodrigues was appointed as chief operations consultant and principal executive officer with a monthly fee of $20,000.
The company agreed to continue D&O insurance for Horowitz for two years and Horowitz agreed to a five-year standstill.
The termination agreement includes mutual releases, confidentiality reaffirmation, and non-disparagement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dominic Rodrigues

Chief Operations Consultant

PVCT · PROVECTUS BIOPHARMACEUTICALS, INC.

Effective: 2024-03-25
Filed: March 26, 2024, 7:59 PM ET

the Board retained Dominic Rodrigues as the Company’s chief operations consultant.

Departed

Bruce Horowitz

Chief Operating Officer

PVCT · PROVECTUS BIOPHARMACEUTICALS, INC.

Effective: 2024-03-25
Filed: March 26, 2024, 7:59 PM ET

On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.

Departed

Bruce Horowitz

Director

PVCT · PROVECTUS BIOPHARMACEUTICALS, INC.

Effective: 2024-03-25
Filed: March 26, 2024, 7:59 PM ET

On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dominic Rodrigues was appointed as Chief Operations Consultant at PROVECTUS BIOPHARMACEUTICALS, INC..

Action: appointed
Role: Chief Operations Consultant

Exact text from the filing

the Board retained Dominic Rodrigues as the Company’s chief operations consultant.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Horowitz resigned as Chief Operating Officer at PROVECTUS BIOPHARMACEUTICALS, INC..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Horowitz resigned as Director at PROVECTUS BIOPHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

On March 25, 2024, Bruce Horowitz resigned from the Board of Directors (the “Board”) of Provectus Biopharmaceuticals, Inc. (the “Company”) and as the Company’s Chief Operating Officer.

View on SEC.gov

PROVECTUS BIOPHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-011327

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.